Palo Alto Networks has added another 7% on the week — yet the options market is more defensive now than it was before the Q3 beat.
The post-earnings analyst reaction has accelerated since the last note. Wedbush's Daniel Ives lifted his target to $300 from $225 on May 27, keeping Outperform. Benchmark raised to $270 the same day. BTIG moved to $268 on May 26. Together with Morgan Stanley, Wells Fargo, Stifel, and Truist — all of which raised targets in the days immediately after the May 20 print — the entire recent analyst tape is one-directional: higher, with no cuts or downgrades. The consensus mean of $230 still trails the $256.75 close, but that aggregate is being dragged upward in real time. The most aggressive current targets — Wedbush at $300, Wells Fargo at $285, and several names at $275 — sit 10–17% above the current price, giving the stock a credible bull case from the Street's standpoint.
Options positioning tells a different story. Defensive hedging has intensified since the Q3 report rather than easing. The put/call ratio has climbed to 1.07 — more than 2.3 standard deviations above its 20-day average of 0.95. That is the most cautious options posture PANW has seen outside of the 52-week high of 1.41. In the days immediately after the earnings-driven rally, PCR was running at 0.94–0.98; it has since ratcheted higher each session. Traders who chased the move up are now buying more downside protection. The Q4 earnings date of June 2 is almost certainly the catalyst anchoring that hedging demand.
Short sellers, meanwhile, have been retreating. Bears hold 3.6% of the free float — down 6% on the week and 8% over the past month — the continuation of a trend that began well before the May 20 results. The borrow market reflects no stress: cost to borrow runs at just 0.51%, up modestly on the week but still comfortably low. Availability is exceptionally loose at over 1,600% of short interest, meaning shares to borrow remain far more plentiful than the existing short position. Short sellers are not adding, the borrow is cheap, and there is no squeeze dynamic. This is a stock bears are quietly exiting into strength.
The CEO's fingerprints are still visible in the shareholder register. Nikesh Arora bought just under 68,100 shares in late March at roughly $147, a $10 million commitment made when the stock was nearly 40% below current levels. Subsequent insider activity has been routine executive-plan selling — the CFO and Chief Accounting Officer both sold small tranches in April — which adds no signal. The Arora purchase remains the most meaningful insider data point, and with the stock now substantially higher, it looks increasingly well-timed.
On valuation, the stock trades at 67x earnings and nearly 47x EV/EBITDA. Both multiples have expanded sharply over the past month — the PE is up roughly 19 turns in 30 days — as the price has run well past consensus. The factor score picture is lopsided: forward EPS growth momentum ranks in the 95th percentile, supporting the bull case that an earnings inflection is arriving. But the EV/EBIT rank sits at the 5th percentile, meaning the stock is priced near the most expensive end of its universe on that metric. The bears' core argument — that European adoption headwinds, competitive pricing pressure, and a high starting multiple limit re-rating room from here — maps directly onto that valuation tension. Peers have broadly followed the sector tailwind: CRWD gained 8.5% on the week, DDOG added 7.1%, and ZS rose 5.7%, while NOW lagged with a 3.4% decline, suggesting the cybersecurity-specific bid rather than pure macro lift.
The next focal point is the June 2 Q4 print — with the stock up 44% in a month and analysts still racing to close the gap between old targets and the current price, the question is less whether PANW is growing and more whether the next quarter's guide justifies the multiple it now carries into the release.
See the live data behind this article on ORTEX.
Open PANW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
